1,800
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Acute kidney injury in group A streptococcal bacteraemia: incidence, outcome and predictive value of C-reactive protein

ORCID Icon, , ORCID Icon, &
Pages 852-860 | Received 26 Jan 2022, Accepted 12 Aug 2022, Published online: 01 Sep 2022

References

  • Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A streptococcal diseases. The Lancet Infectious Diseases. 2005;5(11):685–694.
  • Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements. 2012;2:1–138.
  • Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813–818.
  • Bagshaw SM, Lapinsky S, Dial S, The Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group, et al. Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med. 2009;35(5):871–881.
  • Peters E, Antonelli M, Wittebole X, et al. A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The intensive care Over nations audit. Crit Care. 2018;22(1):188.
  • Poukkanen M, Wilkman E, Vaara ST, FINNAKI Study Group, et al. Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study. Crit Care. 2013;17(6):R295.
  • Kellum JA, Chawla LS, Keener C, ProCESS and ProGReSS-AKI Investigators, et al. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med. 2016;193(3):281–287.
  • Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ. 2019;364:k4891.
  • Md Ralib A, Mat Nor MB, Pickering JW. Plasma neutrophil Gelatinase-Associated lipocalin diagnosed acute kidney injury in patients with systemic inflammatory disease and sepsis. Nephrology. 2017;22(5):412–419.
  • Dai X, Zeng Z, Fu C, et al. Diagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C, and soluble triggering receptor expressed on myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injury. Crit Care. 2015;19(1):223
  • Haase M, Devarajan P, Haase-Fielitz A, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol. 2011;57:1752–1761.
  • Cosentino N, Genovese S, Campodonico J, et al. High-Sensitivity C-Reactive protein and acute kidney injury in patients with acute myocardial infarction: a prospective observational study. JCM. 2019;8(12):2192. Available at:
  • Zhou X, Liu J, Ji X, et al. [Predictive value of inflammatory markers for acute kidney injury in sepsis patients: analysis of 753 cases in 7 years]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018;30:346–350.
  • Katayama S, Nunomiya S, Koyama K, et al. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin. Crit Care. 2017;21(1):229.
  • Nie X, Wu B, He Y, et al. Serum procalcitonin predicts development of acute kidney injury in patients with suspected infection. Clin Chem Lab Med. 2013;51(8):1655–1661. Available at Accessed 13 January 2022.
  • Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. JASN. 2008;19(10):1855–1864.
  • Vilhonen J, Vuopio J, Vahlberg T, et al. Group A streptococcal bacteremias in Southwest Finland 2007-2018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection. Eur J Clin Microbiol Infect Dis. 2020;39(7):1339–1348.
  • Fiorentino M, Tohme FA, Wang S, et al. Long-term survival in patients with septic acute kidney injury is strongly influenced by renal recovery. PLoS One. 2018;13(6):e0198269.
  • Mildh H, Pettilä V, Korhonen A-M, FINNAKI Study Group, et al. Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study. Ann Intensive Care. 2016;6(1):118.
  • Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. In: Critical care (London, England)2004.
  • Chawla LS, Bellomo R, Bihorac A, Acute Disease Quality Initiative Workgroup 16., et al. Acute kidney disease and renal recovery: consensus report of the acute disease quality initiative (ADQI) 16 workgroup. Nat Rev Nephrol. 2017;13(4):241–257.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–3370.
  • Poukkanen M, Vaara ST, Pettilä V, FINNAKI study group, et al. Acute kidney injury in patients with severe sepsis in finnish intensive care units. Acta Anaesthesiol Scand. 2013;57(7):863–872.
  • Björck V, Påhlman LI, Bodelsson M, et al. Morbidity and mortality in critically ill patients with invasive group A streptococcus infection: An observational study. Crit Care. 2020;24(1):302.
  • Bruun T, Rath E, Madsen MB, INFECT Study Group, et al. Risk factors and predictors of mortality in streptococcal necrotizing soft-tissue infections: a multicenter prospective study. Clinical Infectious Diseases. 2021;72(2):293–300.
  • Bagshaw SM, Uchino S, Bellomo R, et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. CJASN. 2007;2(3):431–439.
  • Liu J, Xie H, Ye Z, et al. Rates, predictors, and mortality of sepsis-associated acute kidney injury: a systematic review and Meta-analysis. BMC Nephrol. 2020;21(1):318.
  • Nelson GE, Pondo T, Toews K-A, et al. Epidemiology of invasive group A streptococcal infections in the United States, 2005-2012. Clin Infect Dis. 2016;63(4):478–486.
  • Xu X, Nie S, Liu Z, et al. Epidemiology and clinical correlates of AKI in chinese hospitalized adults. Clin J Am Soc Nephrol. 2015;10(9):1510–1518.
  • Umbro I, Gentile G, Tinti F, et al. Recent advances in pathophysiology and biomarkers of sepsis-induced acute kidney injury. Journal of Infection. 2016;72(2):131–142.
  • Zarbock A, Gomez H, Kellum JA. Sepsis-induced AKI revisited: pathophysiology, prevention and future therapies. Curr Opin Crit Care. 2014;20(6):588–595.
  • Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. The Lancet Infectious Diseases. 2009;9(5):281–290.
  • Shannon BA, McCormick JK, Schlievert PM. Toxins and superantigens of group A streptococci. Microbiol Spectr. 2019;7(1). DOI:10.1128/microbiolspec.GPP3-0054-2018
  • Warnock DG, Neyra JA, Macedo E, et al. Comparison of static and dynamic baseline creatinine surrogates for defining acute kidney injury. Nephron. 2021;145(6):664–674.
  • Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. American Journal of Kidney Diseases. 2014;63(5):713–735.
  • Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDS). Streptococcal Toxic Shock Syndrome | 2010. Case Definition.